Results 211 to 220 of about 269,027 (363)

Myocarditis following COVID‐19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases

European Journal of Heart Failure, Volume 24, Issue 11, Page 2000-2018, November 2022., 2022
Overview on incidence, diagnosis, and therapy in vaccine‐related myocarditis. CMR, cardiac magnetic resonance; EMB, endomyocardial biopsy; NSAIDS, non‐steroidal anti‐inflammatory drugs. Abstract Over 10 million doses of COVID‐19 vaccines based on RNA technology, viral vectors, recombinant protein, and inactivated virus have been administered worldwide.
Bettina Heidecker, Noa Dagan, Ran Balicer, Urs Eriksson, Giuseppe Rosano, Andrew Coats, Carsten Tschöpe, Sebastian Kelle, Gregory A. Poland, Andrea Frustaci, Karin Klingel, Pilar Martin, Joshua M. Hare, Leslie T. Cooper, Antonis Pantazis, Massimo Imazio, Sanjay Prasad, Thomas F. Lüscher   +17 more
wiley   +1 more source

The cardiomyopathies. [PDF]

, 1972
J. F. Goodwin, C M Oakley
openalex   +1 more source

Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)

Clinical Pharmacology &Therapeutics, EarlyView.
Clinical inhibition and genetic variation of the Breast Cancer Resistance Protein (BCRP/ABCG2) efflux transporter can significantly influence drug exposure, highlighting the need for reliable BCRP functional biomarkers. This study aimed to identify and evaluate biomarkers predictive of BCRP function in humans.
Andrew M. Riselli, Sook Wah Yee, Jia Yang, Claire M. Brett, Kelsey Trumbach, Xujia Zhou, Renmeng Liu, Xiaomin Liang, Yurong Lai, Runlan Huo, Yongjun Xue, Hong Shen, Lei Zhang, Xinning Yang, Qi Liu, Shiew‐Mei Huang, Kathleen M. Giacomini   +16 more
wiley   +1 more source

Defective in vitro suppressor cell function in idiopathic congestive cardiomyopathy. [PDF]

, 1979
R E Fowles, C P Bieber, E. B. Stinson
openalex   +1 more source

Limitações da cardiomioplastia no tratamento das cardiomiopatias Cardiomyoplasty limitations in the treatment of severe cardiomyopathies

Brazilian Journal of Cardiovascular Surgery, 1992
A cardiomioplastia melhora a função ventricular esquerda e a sobrevida de pacientes portadores de cardiomiopatias severas. O objetivo deste estudo é identificar os fatores que influenciaram os resultados da cardiomioplastia em 22 pacientes operados entre
Luiz Felipe P Moreira, Edimar A Bocchi, Noedir A. G Stolf, Pedro Seferian Jr, Paulo M Pego - Fernandes, Antônio Carlos Pereira-Barreto, Fúlvio Pileggi, Adib D Jatene   +7 more
doaj  

The systolic murmur in hypertrophic obstructive cardiomyopathy and the nature of the obstruction

, 1968
M Nellen, Mervyn S. Gotsman
openalex   +1 more source

Diabetic cardiomyopathy: the preclinical phase. [PDF]

, 1977
Basil I. Seneviratne
openalex   +1 more source

Enzymic analysis of endomyocardial biopsy specimens from patients with cardiomyopathies. [PDF]

, 1977
T. J. Peters, George Wells, C M Oakley, I A Brooksby, B S Jenkins, M M Webb-Peploe, D J Coltart   +6 more
openalex   +1 more source

Autopsy findings in cases of fatal COVID‐19 vaccine‐induced myocarditis

ESC Heart Failure, EarlyView.
Abstract COVID‐19 vaccines have been linked to myocarditis, which, in some circumstances, can be fatal. This systematic review aims to investigate potential causal links between COVID‐19 vaccines and death from myocarditis using post‐mortem analysis.
Nicolas Hulscher, Roger Hodkinson, William Makis, Peter A. McCullough   +3 more
wiley   +1 more source

The potential of CRISPR-Cas9 in cardiovascular medicine: a focus on hereditary cardiomyopathies. [PDF]

Ann Med Surg (Lond)
Rasheed S, Jha M, Waheed A, Farooq U, Fatima A, Haq IU, Khan U, Wardak AB, Gul MH.   +8 more
europepmc   +1 more source